For most small and mid-size pharma companies, risk reduction is the overarching reason for investing in automated quality management and training management systems. That makes sense because quality and training management systems help ensure adherence to regulatory requirements, and any failure to comply with those standards may result in product delays, fines, and reputation risks.
